Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from
Agilent Technologies Stock: Ready to Rise off the Floor
Agilent Technologies Inc. (NYSE: A) stock is underperforming the market, trading down (19%) year-to-date. Agilent is a leading global provider.
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next.
Roche Holding AG (RHHVF) Gets a Hold Rating from J.P. Morgan
In a report released yesterday, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF370.00. The company's shares closed last...